Walleye Capital’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,646,466
| Closed | -$46.4K | – | 3029 |
|
|
2024
Q2 | $46.4K | Hold |
1,646,466
| – | – | ﹤0.01% | 2163 |
|
|
2024
Q1 | $148K | Hold |
1,646,466
| – | – | ﹤0.01% | 1904 |
|
|
2023
Q4 | $173K | Buy |
1,646,466
+119,984
| +8% | +$12.6K | ﹤0.01% | 1510 |
|
|
2023
Q3 | $343K | Sell |
1,526,482
-16,255
| -1% | -$3.66K | ﹤0.01% | 1281 |
|
|
2023
Q2 | $405K | Buy |
1,542,737
+1,012,135
| +191% | +$265K | ﹤0.01% | 1070 |
|
|
2023
Q1 | $95.5K | Buy |
530,602
+246,442
| +87% | +$44.4K | ﹤0.01% | 1520 |
|
|
2022
Q4 | $56.8K | Buy |
+284,160
| New | +$56.8K | ﹤0.01% | 1605 |
|
|
2022
Q1 | – | Sell |
-241,033
| Closed | -$540K | – | 2601 |
|
|
2021
Q4 | $540K | Buy |
241,033
+209,087
| +655% | +$468K | 0.02% | 917 |
|
|
2021
Q3 | $108 | Buy |
+31,946
| New | +$108 | ﹤0.01% | 1291 |
|